Puma Biotechnology (PBYI) Revenue (QoQ) (2017 - 2026)
Puma Biotechnology (PBYI) Revenue (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - |
| 10 | Puma Biotechnology | 415.91 Mn | 377.63 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.61% |
| Dec 31, 2025 | 38.51% |
| Sep 30, 2025 | 3.89% |
| Jun 30, 2025 | 13.97% |
| Mar 31, 2025 | -22.12% |
| Dec 31, 2024 | -26.65% |
| Sep 30, 2024 | 71.06% |
| Jun 30, 2024 | 7.58% |
| Mar 31, 2024 | -39.36% |
| Dec 31, 2023 | 28.62% |
| Sep 30, 2023 | 2.84% |
| Jun 30, 2023 | 3.40% |
| Mar 31, 2023 | -39.78% |
| Dec 31, 2022 | 53.49% |
| Sep 30, 2022 | -4.06% |
| Jun 30, 2022 | 30.13% |
| Mar 31, 2022 | -17.38% |
| Dec 31, 2021 | 19.70% |
| Sep 30, 2021 | -13.37% |
| Jun 30, 2021 | -45.62% |